BioXcel Therapeutics, Inc. (BTAI)
1.14
+0.05
(+4.59%)
USD |
NASDAQ |
May 21, 16:00
1.11
-0.03
(-2.63%)
After-Hours: 19:59
BioXcel Therapeutics Research and Development Expense (TTM) : 27.94M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Verastem, Inc. | 123.67M |
| Quince Therapeutics, Inc. | 34.08M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| Amgen, Inc. | 7.514B |